Staar Surgical Company2025财年实现净利润-80.45百万美元，同比减少298.07%

市场透视03-09

3月9日，Staar Surgical Company（STAA.US）公布财报，公告显示公司2025财年净利润为-80.45百万美元，同比减少298.07%；其中营业收入为2.39亿美元，同比减少23.89%，每股基本收益为-1.62美元。从资产负债表来看，Staar Surgical Company（STAA.US）总负债1.17亿美元，其中短期债务5.87百万美元，资产负债比为3.95，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2618614296?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-09 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2618614296","market":"us","top_or_hot":-1,"title":"Staar Surgical Company2025财年实现净利润-80.45百万美元，同比减少298.07%","media":"市场透视","content":"<div>\n<p>3月9日，Staar Surgical Company（STAA.US）公布财报，公告显示公司2025财年净利润为-80.45百万美元，同比减少298.07%；其中营业收入为2.39亿美元，同比减少23.89%，每股基本收益为-1.62美元。从资产负债表来看，Staar Surgical Company（STAA.US）总负债1.17亿美元，其中短期债务5.87百万美元，资产负债比为3.95，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000028a4587830&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Staar Surgical Company2025财年实现净利润-80.45百万美元，同比减少298.07%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStaar Surgical Company2025财年实现净利润-80.45百万美元，同比减少298.07%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-09 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000028a4587830&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>3月9日，Staar Surgical Company（STAA.US）公布财报，公告显示公司2025财年净利润为-80.45百万美元，同比减少298.07%；其中营业收入为2.39亿美元，同比减少23.89%，每股基本收益为-1.62美元。从资产负债表来看，Staar Surgical Company（STAA.US）总负债1.17亿美元，其中短期债务5.87百万美元，资产负债比为3.95，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000028a4587830&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000028a4587830&s=b","article_id":"2618614296","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309000028a4587830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2618614296","pubTimestamp":1772985618,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"3月9日，Staar Surgical Company公布财报，公告显示公司2025财年净利润为-80.45百万美元，同比减少298.07%；其中营业收入为2.39亿美元，同比减少23.89%，每股基本收益为-1.62美元。从资产负债表来看，Staar Surgical Company总负债1.17亿美元，其中短期债务5.87百万美元，资产负债比为3.95，流动比率为0.05。机构评级：截至2026年3月9日，当前有10家机构对Staar Surgical Company目标价做出预测，其中目标均价为20.05美元，其中最低目标价为13.00美元，最高目标价为28.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4093":"化肥与农用药剂","BK4588":"碎股","ICL":"以色列化学","STAA":"STAAR Surgical Company","BK4198":"医疗保健用品","BK4548":"巴美列捷福持仓"},"translate_title":"Staar Surgical CompanyFY2025 Net Income of-$80.45 Million, Decrease 298.07% Y/Y","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICL":1,"STAA":0.9},"content_text":"3月9日，Staar Surgical Company（STAA.US）公布财报，公告显示公司2025财年净利润为-80.45百万美元，同比减少298.07%；其中营业收入为2.39亿美元，同比减少23.89%，每股基本收益为-1.62美元。从资产负债表来看，Staar Surgical Company（STAA.US）总负债1.17亿美元，其中短期债务5.87百万美元，资产负债比为3.95，流动比率为0.05。机构评级：截至2026年3月9日，当前有10家机构对Staar Surgical Company目标价做出预测，其中目标均价为20.05美元，其中最低目标价为13.00美元，最高目标价为28.00美元。公司简介：Staar Surgical Co是一家镜片制造商。公司设计、开发、制造和销售用于眼睛的植入式镜片和用于将镜片输送到眼睛中的输送系统。该公司还生产用于白内障手术的隐形眼镜。该公司提供两种类型的产品：植入式晶体（ICL）和人工晶体（IOL）。人工晶体用于屈光手术，人工晶体用于白内障手术。其大部分销售额来自眼科手术产品部分。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618614296","isCrawlerRequest":true}